[go: up one dir, main page]

MX2008002623A - Composiciones y metodos para mejorar la integridad vascular funcional, la supervivencia celular y para reducir la apoptosis en isquemia o despues de un episodio isquemico en el cerebro. - Google Patents

Composiciones y metodos para mejorar la integridad vascular funcional, la supervivencia celular y para reducir la apoptosis en isquemia o despues de un episodio isquemico en el cerebro.

Info

Publication number
MX2008002623A
MX2008002623A MX2008002623A MX2008002623A MX2008002623A MX 2008002623 A MX2008002623 A MX 2008002623A MX 2008002623 A MX2008002623 A MX 2008002623A MX 2008002623 A MX2008002623 A MX 2008002623A MX 2008002623 A MX2008002623 A MX 2008002623A
Authority
MX
Mexico
Prior art keywords
compositions
methods
ischemia
brain
vascular integrity
Prior art date
Application number
MX2008002623A
Other languages
English (en)
Inventor
Yuanlong Pan
Brian Larson
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37243699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2008002623(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2008002623A publication Critical patent/MX2008002623A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se describen composiciones y metodos para mejorar la integridad vascular en animales. Las composiciones y metodos los cuales utilizan acidos grasos poliinsaturados de cadena larga y compuestos liberadores de oxido nitrico tambien son eficaces para reducir el dano en cerebro inducido por isquemia en un animal.
MX2008002623A 2005-08-26 2006-08-25 Composiciones y metodos para mejorar la integridad vascular funcional, la supervivencia celular y para reducir la apoptosis en isquemia o despues de un episodio isquemico en el cerebro. MX2008002623A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71154705P 2005-08-26 2005-08-26
US71154905P 2005-08-26 2005-08-26
PCT/EP2006/008354 WO2007022991A1 (en) 2005-08-26 2006-08-25 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain

Publications (1)

Publication Number Publication Date
MX2008002623A true MX2008002623A (es) 2008-03-18

Family

ID=37243699

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008002623A MX2008002623A (es) 2005-08-26 2006-08-25 Composiciones y metodos para mejorar la integridad vascular funcional, la supervivencia celular y para reducir la apoptosis en isquemia o despues de un episodio isquemico en el cerebro.

Country Status (10)

Country Link
US (3) US20070053955A1 (es)
EP (1) EP1919304B1 (es)
JP (1) JP5371429B2 (es)
AT (1) ATE510464T1 (es)
AU (1) AU2006284088B2 (es)
BR (1) BRPI0615381A2 (es)
CA (1) CA2620024C (es)
MX (1) MX2008002623A (es)
RU (1) RU2400102C2 (es)
WO (1) WO2007022991A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
MX336435B (es) * 2005-07-08 2016-01-19 Dsm Ip Assets Bv Acidos grasos poliinsaturados para el tratamiento de demencia y condiciones relacionadas con pre-demencia.
EP2194781B2 (en) * 2007-10-04 2021-03-24 Société des Produits Nestlé S.A. Compositions and methods for enhancing cognitive function
JPWO2009048120A1 (ja) * 2007-10-11 2011-02-24 日清ファルマ株式会社 アスタキサンチン含有水溶性組成物
CA2704371A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
BRPI0820802A2 (pt) * 2007-12-17 2015-06-16 Univ Florida Materiais e métodos para tratamento de proliferação vascular ocular patológica
BRPI0822238B8 (pt) 2008-01-04 2021-05-25 Nestec Sa composições compreendendo ácidos graxos insaturados e compostos liberadores de óxido nítrico
US20100316732A1 (en) * 2008-02-12 2010-12-16 Todd James Smith Beverage compositions for the promotion of joint health in companion animals
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
BR112012003792B1 (pt) 2009-08-21 2020-05-19 Novan Inc composição tópica, e, uso da composição tópica
WO2011047091A1 (en) * 2009-10-13 2011-04-21 Martek Biosciences Corporation Methods for treating traumatic brain injury
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
RU2597793C2 (ru) * 2011-01-25 2016-09-20 Нестек С.А. Способы и композиции для лечения, ослабления или предотвращения ухудшения зрительной системы животных
US20130324608A1 (en) * 2011-02-18 2013-12-05 Yuanlong Pan Methods and compositions for treating, reducing or preventing damage to the nervous system of animals
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
EP2685987B1 (en) * 2011-03-18 2019-04-24 Nestec S.A. Compositions and methods useful for ameliorating age related maladies
US8551532B2 (en) 2011-11-02 2013-10-08 Kuwait University Method of making an anti-inflammatory composition
PH12017501037B1 (en) * 2014-12-05 2024-04-12 Can Tech Inc Animal feed supplement and method
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JOP20200033A1 (ar) 2017-08-14 2020-02-13 Axcella Health Inc تركيبات حمض أميني لمعالجة مرض كبدي
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
GB9403935D0 (en) * 1994-03-01 1994-04-20 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
GB9510037D0 (en) * 1995-05-18 1995-07-12 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
ES2331724T3 (es) * 2000-04-14 2010-01-14 Mars, Incorporated Composiciones y metodos para mejorar la salud vascular.
DE60135333D1 (de) * 2000-06-01 2008-09-25 Jbs United Inc Tiernahrung sowie verfahren
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
US6930099B2 (en) * 2001-09-07 2005-08-16 Advanced Medical Instruments Composition for the treatment and prevention of endothelial dysfunction
DE10214005A1 (de) * 2002-03-27 2003-10-09 Volker Bartz Blutfettsenker zur oralen Einnahme, bestehend aus einem Gemisch aus den Omega-3-Fettsäuren EPA (Eicosapentaensäure) und DHA (Docosapentaensäure) und Pektin und/oder Guar als wirksame Substanzen, sowie gegebenenfalls zusätzlichen Stoffen wie antioxidative Vitamine, Aminosäuren und Spurenelemente
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20060280776A1 (en) * 2003-09-02 2006-12-14 Masafumi Koide Diet food
EP1640001A1 (en) * 2004-09-24 2006-03-29 New Pharma Investments Holding Composition against cardiovascular diseases

Also Published As

Publication number Publication date
EP1919304B1 (en) 2011-05-25
RU2400102C2 (ru) 2010-09-27
US20070053955A1 (en) 2007-03-08
JP2009505999A (ja) 2009-02-12
BRPI0615381A2 (pt) 2011-05-17
US20070060651A1 (en) 2007-03-15
US20120149777A1 (en) 2012-06-14
EP1919304A1 (en) 2008-05-14
WO2007022991A1 (en) 2007-03-01
RU2008111494A (ru) 2009-10-10
AU2006284088A1 (en) 2007-03-01
JP5371429B2 (ja) 2013-12-18
ATE510464T1 (de) 2011-06-15
CA2620024C (en) 2014-11-18
CA2620024A1 (en) 2007-03-01
AU2006284088B2 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
MX2008002623A (es) Composiciones y metodos para mejorar la integridad vascular funcional, la supervivencia celular y para reducir la apoptosis en isquemia o despues de un episodio isquemico en el cerebro.
WO2007001883A3 (en) Method to reduce oxidative damage and improve mitochondrial efficiency
ZA200806111B (en) Compositions and methods for preserving brain function
IL180844A0 (en) Compositions and methods for treating excessive bleeding
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
BRPI0818732A2 (pt) Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.
PL1800675T3 (pl) Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
HN2000000266A (es) Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
CR9558A (es) Formulaciones de quinina
WO2016149501A3 (en) Modified therapeutic agents and compositions thereof
DK1809328T3 (da) Mannooligosaccharid-sammensætning til kropsfedt-reduktion
NL1031626A1 (nl) Verbindingen die bruikbaar zijn in therapie.
PL1765318T3 (pl) Średniołańcuchowe kwasy tłuszczowe przydatne jako środki przeciwdrobnoustrojowe
GB0722578D0 (en) Methods and compositions for delaying the release of treatment chemicals
WO2006081388A3 (en) Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
WO2007041418A3 (en) Methods and compositions for improving cognitive function
EP1917978A4 (en) MEANS OF PREVENTING PREVIOUS OVULATION
CL2005003456A1 (es) Proceso de preparacion del beta-anomero enriquecido de clorhidrato de gemcitabina; compuesto intermediario involucrado en dicho proceso; y su proceso de preparacion.
IL185653A (en) Antibodies that call for the 1-kim salt region
CL2018001069A1 (es) Método para reducir la pérdida de nutrientes
ZA200802635B (en) Compositions and methods for improving functional vascular intergrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain
AR049368A1 (es) Agente parasiticida
GB0505046D0 (en) Fish bait and methods for the process thereof
BRPI0616418A2 (pt) método para produzir um l-aminoácido
ES1060179Y (es) Accesorio para el corte de dados y fileteados de productos alimenticios.

Legal Events

Date Code Title Description
FG Grant or registration